A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Ferreri, Kevin, Ph.D. Bookmark and Share

Ferreri, Kevin Ph.D. Research

Islet Cell Biology
Islet cell therapy is a very promising treatment for type 1 diabetes, but suffers from variability in the cell preparations used for transplantation. As part of this clinical program, my group has developed several new approaches for islet cell characterization, including metabolic parameters and gene expression profiling for evaluation of the islet cells prior to transplantation. Glucose stimulates insulin secretion from islets, and we are quantifying this response by the oxygen consumption rate and changes in cytochrome reduction. We have shown that these parameters have a high correlation with the ability of islets to reverse diabetes, and therefore identify “good” islet preparations. In a parallel study, we completed the gene expression profiling of several islet preparations and have identified a “gene signature” of islet quality. This geneset accurately predicts in vivo efficacy of transplanted islets, and we are developing a diagnostic test for islet function. We are also exploring the functional roles of these genes, which should lead to a better understanding of islet biology and better treatments for diabetics.
 
Circulating Nucleic Acids
A major difficult in both islet transplantation therapy and in diabetes in general is the lack of diagnostic tests that can be used to monitor islets in vivo. Based on the hypothesis that dying islet cells release cell debris into circulation, my group is measuring specific nucleic acids in the blood of our islet recipients and new onset diabetic patients. We have developed a highly sensitive and specific method to detect DNA from transplanted islets in the recipient’s circulation and find that the levels correlate with damage to the islet grafts. Recently we developed a similar test based on a unique DNA pattern we discovered for early detection of type 1 diabetes. These early markers of islet injury will allow timely intervention to prevent further loss of islet cells. We are building on these approaches to develop biomarkers for type 2 diabetes and diabetic complications.
 

Kevin Ferreri, Ph.D., Lab Members

Kevin Ferreri, Ph.D.
Associate Research Professor
626-256-HOPE (4673) ext.  65021
 
Mohamed El-Sayed, Ph.D.
Staff Scientist
626-256-HOPE (4673) ext.  31247
 
Alexander Kaye
Research Associate I
626-256-HOPE (4673) ext.  31218
 

Ferreri, Kevin, Ph.D.

Ferreri, Kevin Ph.D. Research

Islet Cell Biology
Islet cell therapy is a very promising treatment for type 1 diabetes, but suffers from variability in the cell preparations used for transplantation. As part of this clinical program, my group has developed several new approaches for islet cell characterization, including metabolic parameters and gene expression profiling for evaluation of the islet cells prior to transplantation. Glucose stimulates insulin secretion from islets, and we are quantifying this response by the oxygen consumption rate and changes in cytochrome reduction. We have shown that these parameters have a high correlation with the ability of islets to reverse diabetes, and therefore identify “good” islet preparations. In a parallel study, we completed the gene expression profiling of several islet preparations and have identified a “gene signature” of islet quality. This geneset accurately predicts in vivo efficacy of transplanted islets, and we are developing a diagnostic test for islet function. We are also exploring the functional roles of these genes, which should lead to a better understanding of islet biology and better treatments for diabetics.
 
Circulating Nucleic Acids
A major difficult in both islet transplantation therapy and in diabetes in general is the lack of diagnostic tests that can be used to monitor islets in vivo. Based on the hypothesis that dying islet cells release cell debris into circulation, my group is measuring specific nucleic acids in the blood of our islet recipients and new onset diabetic patients. We have developed a highly sensitive and specific method to detect DNA from transplanted islets in the recipient’s circulation and find that the levels correlate with damage to the islet grafts. Recently we developed a similar test based on a unique DNA pattern we discovered for early detection of type 1 diabetes. These early markers of islet injury will allow timely intervention to prevent further loss of islet cells. We are building on these approaches to develop biomarkers for type 2 diabetes and diabetic complications.
 

Lab Members

Kevin Ferreri, Ph.D., Lab Members

Kevin Ferreri, Ph.D.
Associate Research Professor
626-256-HOPE (4673) ext.  65021
 
Mohamed El-Sayed, Ph.D.
Staff Scientist
626-256-HOPE (4673) ext.  31247
 
Alexander Kaye
Research Associate I
626-256-HOPE (4673) ext.  31218
 
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...
  • Neural stem cells have a natural ability to seek out cancer cells in the brain. Recent research from the laboratories of Michael Barish, Ph.D., and Karen Aboody, M.D., may offer a new explanation for this attraction between stem cells and tumors. Prior to joining City of Hope, Aboody, now a professor in the Dep...
  • The American Society of Clinical Oncology, a group that includes more than 40,000 cancer specialists around the country, recently issued a list of the five most profound cancer advances over the past five decades. Near the top of the list was the introduction of chemotherapy for testicular cancer. To many in th...
  • “The dying, as a group, have been horribly underserved.” So says Bonnie Freeman, R.N., D.N.P., A.N.P.-B.C., A.C.H.P.N., a nurse practitioner in the Department of Supportive Care Medicine at City of Hope. After nearly 25 years, primarily in critical care nursing, Freeman saw that the needs of the dying were ofte...
  • “Are we the only ones who feel this way?” Courtney Bitz, L.C.S.W., a social worker in the Sheri & Les Biller Patient and Family Resource Center at City of Hope, often hears this question from couples trying to cope with a breast cancer diagnosis and still keep their relationship strong. The ques...
  • Diabetes investigators at City of Hope are studying the full trajectory of diabetes and metabolic disorders, as well as complications of the disease. One especially promising approach focuses on proteins known as growth factors. Led by Fouad Kandeel, M.D., Ph.D., chair and professor of the Department of Clinica...
  • Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades ago, in 1996, the National Comprehensive Cancer Network (NCCN) published its first guidelines for treatment of acute myeloid leukemia, or AML. Margaret O’Donnell, M.D., assoc...
  • Children diagnosed with cancer are more likely than ever before to survive the disease, but with a potential new set of health problems caused by the cancer treatment itself. Those problems can particularly affect the heart, and as doctors and other health care workers try to assess how best to care for this sp...
  • Karen Reckamp, M.D., M.S., has an office next to my own, and we often see patients at the same time. As such, I’ve gotten to know her quite well over the years, and I’ve also gotten a glimpse of many of her patients. She specializes in lung cancer, and most of her patients have tumors […]
  • Today is National Doctors Day, the official day to recognize, thank and celebrate the tremendous work physicians do each and every day. Launched in 1991 via a presidential proclamation from then-President George Bush, the observance offers a chance to reflect on the qualities that define truly great medical car...
  • When considering cancer risk, categories like “women’s cancers” and “men’s cancers” may not matter. A complete medical history, especially of first-degree relatives, must be considered when evaluating risk. A new study drives home that fact. Published in the journal Cancer, the study found a link between a fami...
  • Precision medicine holds promise – on that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers. It can’t be. Researchers and scientists are st...
  • Frank Di Bella, 70, is on a mission: Find a cure for metastatic bladder cancer. It’s just possible he might. Although Di Bella isn’t a world-renowned physician, cancer researcher or scientist, he knows how to make things happen. For more than 20 years, he served as chairman of annual fundraising gal...
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...